How often do sentinel lymph node biopsy results impact adjuvant therapy decisions among postmenopausal women with early stage, HR+/HER2= breast cancer in the post-RxPonder era? Meeting Abstract

  

Authors:	Pilewskie, M.; Sevilimedu, V.; Eroglu, I.; Le, T.; Wang, R.; Morrow, M.; Braunstein, L.
Abstract Title:	How often do sentinel lymph node biopsy results impact adjuvant therapy decisions among postmenopausal women with early stage, HR+/HER2= breast cancer in the post-RxPonder era?
Meeting Title:	23rd Annual Meeting of the American Society of Breast Surgeons
Journal Title:	Annals of Surgical Oncology
Volume:	29
Issue:	Suppl. 1
Meeting Dates:	2022 Apr 6-10
Meeting Location:	Las Vegas, NV
ISSN:	1068-9265
Publisher:	Springer
Date Published:	2022-04-01
Start Page:	S302
End Page:	S303
Language:	English
ACCESSION:	WOS:000780965900220
PROVIDER:	wos
DOI:	10.1245/s10434-022-11703-0
Notes:	Meeting Abstract: 1146189 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/195302